Rising Musculoskeletal Burden in Australia

Musculoskeletal (MSK) conditions were among the top 5 contributors to Australia's overall disease burden in 2024, affecting millions of people and placing significant pressure on the healthcare system. According to national health statistics, MSK disorders account for more than 12% of the total disease burden in Australia and nearly 25% of all non fatal health conditions.

Approximately 7.3M Australians, or around 29% of the population, are living with MSK conditions. The most common conditions include back pain affecting about 4M people, arthritis impacting around 3.7M, and bone related conditions affecting roughly 850,000 individuals.

Age is a major contributing factor. Nearly 70% of Australians aged 75 and older experience MSK conditions, compared with about 25% of people aged 25 to 44. As Australia's population continues to age, the demand for orthopedic treatment, rehabilitation, and long term disease management is expected to grow.

Significant Healthcare Expenditure

The economic impact of MSK conditions is substantial. In 2020 to 2021, Australia spent approximately US$9.58B on MSK related healthcare.

Hospital services accounted for the largest share of spending at 67.5%, followed by primary care at 22.4% and referred services such as diagnostic imaging at 10.1%.

Hospital activity also reflects the scale of the challenge. In 2021 to 2022, Australia recorded around 745,100 hospitalisations related to MSK conditions. These conditions also ranked first in private hospital expenditure at approximately US$3.58B and second in imaging related expenditure at about US$615M.

For the medical technology industry, these figures highlight sustained demand for orthopedic implants, surgical systems, diagnostic equipment, and rehabilitation devices.

Growth Across Multiple Orthopedic Device Segments

Many orthopedic segments are expected to experience steady growth in Australia as healthcare providers adopt more advanced treatment solutions:

• Orthopedic surgical robotics: Projected to grow from US$10.3M in 2023 → US$21.9M by 2030
• Smart orthopedic implants: Expected to grow from US$722.4M in 2022 → around US$1.15B by 2030
• Endoscopic systems: projected to grow from US$741.6M in 2025 → US$970.7M by 2030
• Orthopedic braces and supports: expected to reach US$188.2M by 2030
• Orthopedic imaging equipment: projected to grow to US$139.7M by 2030
• Platelet rich plasma therapies: projected to grow from US$6.3M in 2025 to US$18.1M by 2033, reflecting a CAGR of around 14%

These developments reflect a broader shift toward minimally invasive procedures, regenerative therapies, and technology driven orthopedic care.

"Own Your Health": Policy Initiatives Supporting MSK Management

In addition to clinical demand, national initiatives are supporting better management of chronic MSK conditions. In 2022, Musculoskeletal Australia proposed the "Own Your Health" initiative, a US$2.88M program running from 2022 to 2026.

The initiative focuses on improving patient outcomes through self care education, digital tools, and community support programs. Such efforts highlight growing interest in preventive care and long-term disease management solutions.

Market Outlook

With a large patient population, rising healthcare expenditure, and increasing adoption of advanced technologies, Australia presents a promising market for orthopedic medical devices.

For manufacturers evaluating entry, understanding TGA regulatory requirements is an important first step. With Qualtech's experience for Australian regulatory landscape, we provide insights to support medical device players assessing regulatory pathways and market entry considerations.

References

1. Chronic musculoskeletal conditions, Summary - Australian Institute of Health and Welfare
2. Australia Orthopedic Surgical Robots Market Size & Outlook
3. Australia Endoscopy Devices Market Report _ Industry Analysis, Size & Growth Trends
4. Australian Burden of Disease Study 2024
5. OWN YOUR HEALTH: Implementing a comprehensive selfcare initiative for Australians with musculoskeletal conditions
6. Australia Orthopedic Imaging Equipment Market Size & Outlook
7. Australia Platelet Rich Plasma (prp) Market Size & Outlook
8. Australia Smart Orthopedic Implants Market Size & Outlook
9. Australia Orthopedic Braces And Supports Market Size & Outlook